Monday - American Association for Thoracic Surgery

Transcription

TH
96
AATS
DAI LY
NEW S
2016
MONDAY EDITION
MONDAY
6:30 a.m.
Update on Maintenance of Certification
Information Breakfast for the American
Board of Thoracic Surgery
7:20 a.m.
Business Session
AATS Members Only
7:30 a.m.
Plenary Scientific Session
8:50 a.m.
Award Presentations
9:05 a.m.
Intermission – Visit Exhibits/Coffee
Break
Basic Science Lecture
Monday at 9:45 a.m.
Gary H. Gibbons, MD,
Director of the National
Heart, Lung, and Blood
Institute
10:25 a.m.
11:05 a.m.
New Member Induction
11:25 a.m.
Presidential Address
Competition: Perspiration to Inspiration
“Aut viam inveniam aut faciam”
Joseph S. Coselli, MD
Baylor College of Medicine
Continued on page 4
Presidential
Address
Monday, May 16
11:25 a.m.
Competition:
Perspiration to
Inspiration “Aut
viam inveniam
aut faciam”
Joseph S. Coselli,
MD
Baylor College of
Medicine
DR. COSELLI
MAY 14-18, 2016 • BALTIMORE CONVENTION CENTER • BALTIMORE, MD
Adult Cardiac Skills Course Focused on
Minimizing Concerns in Complex Surgeries
P
reparing for complex cardiac surgery can be intimidating, but in
Saturday’s Adult Cardiac Skills
Course, “Demystifying Complex
Cardiac Surgery – Minimizing the
Fear Factor,” chair Edward P. Chen,
MD, of Emory University, Atlanta,
and co-chair Gebrine El Khoury, MD,
of Université Catholique de Louvain
(Belgium) chose speakers and topics
perfectly suited to the task.
A topic of particular interest was
the difficulties of dealing with endocarditis in both the prosthetic and the
native heart valve discussed by Gosta
B. Pettersson, MD, Cleveland Clinic,
and Dr. El Khoury, respectively.
Dr. Pettersson addressed the differences in the pattern of infection
that occurred with native valves as
compared with prosthetic. In native
valves, infection occurred from a
single point and could spread across
other tissues, whereas with prosthetic
valves, infection tended to be more
localized, resulting in the degeneration of the implanted valve itself.
“You can often see how the bacteria produce enzymes, which disintegrate the tissue,” said Dr. Pettersson.
This pattern can make it easier to
Adult Cardiac continued on page 6
Gosta B. Pettersson, MD, PhD,
discussed patterns of infection
observed in valves.
Surgical Ethics: From Scarcity,
to Honesty, to Hope
ourse chairs Martin F. McKneally, MD, of the UniversiC
ty of Toronto, and Robert M. Sade, MD, of the Medical University of South Carolina, Charleston, presented a
MD, of Jefferson Medical College, Philadelphia, addressed
the growing concern over the costs and utility of LVADs.
“[Left ventricular assist devices] are a very expensive
day-long program that focused on the ethical issues faced therapy that can improve the length and quality of life for
by practicing surgeons, especially in a world where new
a patient with advanced heart failure. Implantation into
technologies are rapidly evolving.
patients with a low chance for success is not a prudent
In the Keynote Address, Larry Churchill, PhD, of Vanuse of resources, and is thus ethically inappropriate from
derbilt University, Nashville, Tenn.,
a utilitarian viewpoint,” said Dr.
focused on the working virtues necEntwistle. He discussed the varessary in surgical practice and how
ious parameters which could be
to transmit these essential character
used to justify the use of LVADs
traits to the next generation of
in any particular patient.
surgeons. He stressed the necessity
The most all-embracing ethical
of communication with and caring
mode, the “rule of rescue,” which
for the patient, the value of authenjustifies nearly any expense used
tic hope (grounded in realism) as
to save someone’s life (as seen
compared with boundless optimism
with the extravagant expense of
rooted in new technologies and the
attempted sea rescues), might
American psyche, and the imporsuggest that cost should have
tance of knowing what should be
no bearing on decisions made in
done, vs. what can be done.
preserving any of these patients’
Larry Churchill, PhD, offered insights on
Switching to the ethical issues
lives. But this approach is not ecoconveying values to the next generation of
arising from the use of new technomically viable given the finite
Surgical Ethics continued on page 4
nologies, John W. C. Entwistle, III, surgeons.
4
AATS 96TH ANNUAL MEETING
Surgical Ethics continued from page 1
resources available for health care.
LVADs can cost hundreds of thousands of dollars over a short time
and costs are even higher for those
patients for which these devices
provide limited survival benefits,
according to Dr. Entwistle.
“If the rule of rescue is invoked
on a VAD candidate to implant a
very expensive device with a low
chance of success, it should be
limited to select cases where there
is potential for many years of life
gained,” he suggested. This way
of thinking enables the development of a cost-benefit risk assessment model for patients receiving
LVADs, similar to models used for
determining the priority of organ
transplants.
Although LVADs are extremely
expensive now, one important
aspect promoting their use is the
fundamental concept of improving technologies and innovation –
if they are used and studied, there
is a much greater likelihood of
significant improvements in their
survival benefits and decreases
in cost, as with other innovative
technologies developed in the
past, according to Dr. Entwistle.
J. Scott Millikan, MD, Billings
Clinic, Mont., addressed another
J. Scott Millikan, MD, reflected on
ethical issues of transplantation.
Continued from page 1
12:30 p.m.
Ethics Forum Lunch
“Should a Surgeon Comply
with Hospital Administration’s
Demand to Change Valve Preference?”
Separate registration required
12:30 p.m. – 2:00 p.m.
AATS/TSRA Preparing Yourself
for an Academic Career Luncheon
Pre-registration required.
2:00 p.m. – 5:00 p.m.
Adult Cardiac Surgery
Congenital Heart Disease
General Thoracic Surgery
Perioperative Care
BALTIMORE CONVENTION CENTER • MAY 14-18, 2016
of the most controversial areas of
modern thoracic surgery, that of
the ethics of scarcity as it applies
to cardiopulmonary organ transplantation.
Dr. Millikan discussed the secular and religious aspects regarding
the definition of death, the disposal of one’s own body, financial
incentives vs. gifting, and the nature of donor and family consent
as key ethical components at the
level of procurement.
The level of organ allocation is
also fraught with ethical dilemmas,
according to Dr. Millikan. Concepts
of justice and equitable distribution
when facing scarcity can compete
with issues of first come first serve,
most sick vs. less sick, and so-called
worthy recipients vs. less worthy,
whether based on moral, medical,
or societal judgments.
“In the end, allocation methods
must try to balance efficiency
and utility, which may be unjust
on the one hand, vs. fairness and
justice, which may be inefficient,”
Dr. Millikan concluded.
Other presentations in the course
discussed the complex ethical issues
revolving around the reporting of
surgeon outcomes, conflicts between the expectations of caregivers and the family, and dealing with
a patient’s desire to die.
John W. C. Entwistle III, MD, spoke
about the ‘rule of rescue.’
5:00 p.m.– 6:40 p.m.
19th Annual C. Walton Lillehei
Resident Forum
Supported by an Educational Grant
from St. Jude Medical
5:00 p.m. – 6:30 p.m.
Innovations in Transcatheter
Aortic Therapies: What You
Need to Know for Today and
the Future
5:00 p.m. – 6:30 p.m.
Emerging Interfaces in Advanced Imaging and Interventions in Structural CV Disease
Supported by an Educational
Grant from Siemens
TUESDAY
Focusing on End-Stage
Thoracic Organ Failure
T
he Saturday session, Optimal Therapies for End-Stage Thoracic Organ Failure, was presented by chair
R. Duane Davis Jr., MD, of Florida
Hospital, Orlando, and co-chair Ashish
S. Shah, MD, of Vanderbilt University,
Nashville, Tenn., focusing on the use
of ECMO, mechanical circulatory support, and transplantation.
Sebastian V. Rojas, MD, Hannover
(Germany) Medical School, presented
the European experience with two
novel mechanical circulatory support
devices. He replaced Jan D. Schmitto,
MD, also of the Hannover Medical
School, as speaker.
Dr. Rojas presented data on the
HeartMate 3, including the positive
initial experiences seen in the CE Mark
trial, including high survival rates, material improvement in functional status, and very low adverse event rates
highlighted by zero pump thrombosis
events with high 30-day and 6-month
survival rates. The device received its
CE mark in October 2015, and has
been implanted at many centers in Europe on a commercial basis.
The other “very promising LVAD
technology” Dr. Rojas discussed is the
MVAD (miniature VAD; HeartWare
Inc.). Its clinical CE Mark trial was started in July 2015 in Europe. However, in
autumn 2015 HeartWare Inc. decided to
perform a voluntary pause of the trial
due to issues with the device’s controller.
Carmelo A. Milano, MD, Duke University, Durham, N.C., presented the
results of the ENDURANCE trial, comparing the HeartWare and HeartMate
II LVADs as destination therapy for patients ineligible for transplant, and of the
ROADMAP trial comparing the HeartMate II with optimal medical therapy.
7:00 a.m. – 8:40 a.m.
Cardiac Surgery Forum
General Thoracic Surgery Forum
Video Session
VAD/ECMO
Adult Cardiac Emerging Technologies & Techniques
General Thoracic Emerging
Technologies & Techniques
8:45 a.m.
10:30 a.m.
Award Presentations
11:40 a.m.– 12:30 p.m.
Honored Guest Lecture
Brian Kelly,
Notre Dame Head Football
Coach
Sebastian V. Rojas, MD, presented data
on two new MCS devices.
Carmelo A. Milano, MD, gave an update
on the ENDURANCE and ROADMAP trials.
The major issue with these devices
is a high stroke rate, according to Dr.
Milano, despite their other benefits to
survival. “As we approach earlier-stage
patients, we really have to discuss with
them what it is like to get an LVAD,”
said Dr. Milano. “They are likely to experience improvements in their functional status and feel better, be able
to do more, but on the other hand,
they will also experience important increased rates in LVAD-related adverse
events,” Dr. Milano concluded.
12:45 p.m.
Moderated Poster Competitions
Exhibit Hall
12:45 p.m. – 1:45 p.m.
NEW Cardiac Studies in Progress
2:00 p.m. – 3:20 p.m.
NEW
NEW CT Surgical Trials Network: Implications for Clinical
Practice
2:00 p.m. – 5:30 p.m.
Aortic/Endovascular Surgery
3:30 p.m. – 4:00 p.m.
Congential and General
Thoracic Deep Dive Sessions
Exhibit Hall
5:35 p.m.
Executive Session
AATS Members Only
7:30 p.m. – 10:00 p.m.
Attendee Reception
The B & O Railroad Museum
Separate ticket required.
WEDNESDAY
7:30 a.m. – 9:45 a.m.
Simultaneous Scientific
Sessions:
9:50 a.m.
Masters of Surgery Video
Sessions:
11:30 a.m.
Annual Meeting Adjourns
6
Adult Cardiac continued from page 1
perform a one-step debridement of
all the foreign tissue, he pointed out.
He stressed the importance of protecting the coronary arteries during
all cases of debridement, pointing
out that they are never infected and
“they can always be preserved.”
Unfortunately, stroke is an all too
common postoperative event in
these patients because they are often
extremely ill to begin with and the
procedure has its risks. “I have been
talking to patients after surgery and
half an hour later they suffer a devastating stroke,” Dr. Pettersson said. As
with all cases of endocarditis, antibiotic therapy provides the only ultimate
cure, he said, and resistant microorganisms are thus always a concern.
In video case presentations, Dr. El
Khoury showed examples of treating
endocarditis of native valves, with
both single and multiple valve involvement, for example, an abscess
occurring between the aortic and the
mitral valves, and a case involving
the aortic and the tricuspid valve.
“Success in these cases requires careful preparation and then dissection
of the infected tissue, making sure to
not go too far,” Dr. El Khoury stated.
The use of the TAVR valve-in-valve
treatment for aortic bioprosthetic
degeneration is becoming more commonplace, according to Bradley G.
Leshnower, MD, of Emory University, standing in for Vinod H. Thou-
Gebrine El Khoury, MD, spoke on
endocarditis of native valves.
Bradley G. Leshnower, MD, discussed
valve-to-valve procedures.
Friedrich W. Mohr, MD, stressed the
value of 3-D echocardiography.
rani, MD, his colleague also from
Emory University.
“You want to consider three main
issues when doing valve-in-valve procedures,” said Dr. Leshnower. The
first is selecting the appropriate insertion valve for the failing bioprosthetic
valve. The second is paying attention
to the coronary ostia and not occluding native flow by using an insertion
valve with projecting components
that might be of concern. It is also
important to protect the coronaries
and be able to access them after valve
deployment if necessary.
“Your final main concern is leaving the patient with residual aortic
stenosis,” he said, presenting data of
how this can result in extremely poor
outcomes.
Dr. Leshnower went over many
of the available valves, detailing the
problems and benefits of each as orig-
inal and valve-in-valve replacement
choices. Proper sizing and choice of
the replacement valve is a critical issue
and one of the most important factors
in success. In describing the procedure
and its results, he pointed out that ultimately, some paravalvular leaks must
be accepted, and “that is a limitation of
the technology and you’re not going to
change that,” Dr. Leshnower said.
“But the field of valve-in-valve replacement is increasing, of that there
is no doubt. Proper configuration
of placing the replacement valves
remains controversial and is different
for each type of valve you’re treating.
There’s no long-term data at this
point,” he stated.
“But we strongly believe that standard care is still remedial aortic valve
replacement in low- and medium-risk
patients, and to some degree, in highrisk patients,” particularly where it
may be deemed appropriate due to
their original type of valve, Dr. Leshnower concluded.
Similarly, the TAVR valve-in-valve
procedure is becoming more common
for the treatment of mitral prosthetic
degeneration, according to Friedrich
W. Mohr, MD, Herzzentrum Leipzig
(Germany), who discussed the options
and difficulties that surgeons faced
using a case study of a 72-year-old
woman. He stressed the value of 3-D
echocardiography in performing these
procedures in order to monitor and
validate results.
Other procedures discussed
throughout the day-long session focused on revascularization, including
the latest CABG techniques, dealing
with acute and chronic pulmonary
embolism, aortic root surgery, and
the difficulties of dealing with aortic
arch repair and aortic dissections.
nce again in 2016,
O
the AATS Annual Meeting Mobile
App will include
everything you need
to know about this
year’s events. The
App is available
through iTunes Store,
Android Market, and
the AATS website!
The App offer attendees the full AATS
meeting experience
right in the palm of
their hand. You can
access every detail of
the aortic symposium
and annual meeting,
including the scientific program,
speakers, exhibitors, meeting locations, attendees and Baltimore
attractions and information.
To log in:
Username: The
numeric code on the
lower right of your
meeting badge
Password: Last
name (as entered on
your registration)
Additional features
include:
• A complete upto-date schedule of
what’s happening.
• Interactive Exhibit Floor with Exhibitor List
• Floor plans for
the Convention Center and hotel meeting
rooms.
• Info Booth with general information on the Annual Meeting.
BARRY EAGEL/W IKIMEDIA COMMONS
AATS 2016 Annual Meeting
Mobile App
AATS Attendee Reception at the
B&O Railroad Museum
Annual Attendee RecepT17,hetionfromAATS
will be held on Tuesday, May
7:30 p.m. to 10:00 p.m. at the
B&O Railroad Museum, home to the
oldest and most comprehensive collection of railroad history in the Western
Hemisphere. The Baltimore & Ohio
Railroad Museum’s roster of rolling
stock, historic buildings and assortment
of small artifacts make it a mecca of
American railroading. The collection
covers almost every aspect of an industry interwoven into the folklore and
culture of America. The Museum’s
collection dates from the very first days
of the B&O Railroad with the laying of
the First Stone on July 4, 1827. Also on
display are hundreds of models ranging
from early patent and prototype models to modern commercial railroads.
Known as the “Industrial Cathedral” the
museum takes visitors back in time.
Tickets are $85.00 and available
when you register online or may be
purchased onsite at the Registration
desk at the Convention Center.
8
AATS Aortic Symposium sets attendance record
A
record-setting 1,200 cardiologists
and cardiothoracic surgeons
gathered in New York on May
12 and 13 to hear a host of international speakers report on and debate
the latest studies on aortic surgery.
This was the 15th version of the
symposium held every other year
since 1988, the last five under the auspices of co-course director Steven L.
Lansman, MD, of Westchester Medical Center, N.Y., The attendance was
the largest yet, Dr. Lansman said.
“In the selective field of aortic surgery, we try to bring together experts
from all over the world to share their
knowledge,” said co-director Joseph
S. Coselli, MD, Baylor College of
Medicine, Houston.
In his opening remarks, Dr. Coselli
said, “Many of us believe that if you
want to share information on the
aorta or learn more about the aorta,
there’s really no better place than every other year at this gathering.”
Because the meeting is approaching its third decade, Dr. Coselli
acknowledged the contributions of
Randall Griepp, MD, and his wife,
Eva Griepp, MD, “for having poured
their heart and soul into this meeting
all these years. We wouldn’t be here
if it wasn’t for their foresight.”
“Throughout this series it has been
our goal to convene an international group whose work is influential
in the current thinking of aortic
surgery,” Dr. Lansman said in his
opening remarks. “We’ve really had
spectacular faculty over the years and
really great discussions. Sometimes
the discussions have been thoughtful,
sometimes the discussions were humorous, and sometimes there were
heated debates.”
To measure up to that standard, the
program committee invited presentations on a number of early and interim
results of ongoing clinical trials. Thomas G. Gleason, MD, of the University
of Pittsburgh presented preliminary
findings from the STABLE II trial of
complicated type B aortic dissection.
Santi Trimarchi, MD, of the University
of Milan gave updates on the ABSORB
trial of high-risk, non-complicated type
B aortic dissection, as well as changes
in the operative strategy for patients
in the International Registry of Acute
Aortic Dissection (IRAD) Interventional cohort. Mohamad Bashir, MD, of
Liverpool (England) Heart and Chest
Hospital gave an update on a national
study of acute aortic dissection in the
This year’s top abstracts were made available on the AATS Aortic Symposium
website and on a Presentations on Demand system, available on iPad kiosks
located in several locations in the exhibit and break areas.
United Kingdom, and Li-Zhong Sun of
Capital Medical University in Beijing
reported on a large study of total aortic
arch replacement and frozen elephant
trunk for acute type A aortic dissection.
Friday breakfast sessions featured
two separate panels on open and endovascular repair called “Stump the
Stars,” in which attendees submitted
cases beforehand and then listened
as experts weighed in on what they
would do in each case. Nicholas
Kouchoukos, MD, of the Missouri
Baptist Medical Center, St. Louis, and
David Spielvogel, MD, Westchester
Medical Center, Valhalla, N.Y., moderated the open surgery panel, and
Joseph Bavaria, MD, of the University
of Pennsylvania, Philadelphia, and
G. Chad Hughes of Duke University
Medical Center, Durham, N.C., the
endovascular panel.
A third breakfast session featured
two different debates: Edward Chen,
MD, of Emory University, Atlanta,
and Leonard Girardi, MD, of Cornell
University, New York, tackled root
repair vs. Bentall procedure for bicuspid aortopathy; then Ali Khoynezhad,
MD, of Cedars-Sinai Heart Institute,
Los Angeles, and Joel Corvera, MD,
Indiana University Health Methodist Hospital, Indianapolis, debated
whether TEVAR or open repair was
better for chronic type B aortic dissection.
Themes for the general sessions
were aortic surgery overview, congenital aortic disease, aortic root,
aortic arch, type A dissection, type
B dissection, malperfusion, and
descending and thoracoabdominal
issues. Attendees took to the microphones with a multitude of questions
and comments during the 45-minute
discussion panels that closed the sessions each morning and afternoon.
In all, the symposium provided more
than 18 hours of CME.
The program committee reviewed
333 abstracts, not all of which could
make it to the podium, but, Dr.
Coselli said, the symposium provided
multiple opportunities to give the top
abstracts exposure, most notably on
the AATS Aortic Symposium website as well as a “POD” system, or
Presentations on Demand, where attendees could view the abstracts and
slide presentations on several iPad
kiosks in the exhibit and break areas.
Eighteen abstracts received Plenary
Citations, getting added exposure in
overviews from session moderators
between presentations, and the program committee selected 37 for Directors’ Choice designation.
The abstract which ranked highest
received the Griepp Paper honor.
Florian Schoenhoff, MD, and his colleagues at Johns Hopkins University,
Baltimore, and University Hospital
Bern, Switzerland, received the honor for “Management of the Aortic
Arch in Loeys-Dietz Syndrome.”
Dr. Griepp personally presented the
award to Dr. Schoenhoff.
The program committee also kept
track of the institutions that submitted the most abstracts, and Dr.
Lansman gave a rundown of them:
University of Texas, Houston, 23;
Liverpool Heart and Chest Hospital,
12; University of Leipzig, Germany,
11; University of Colorado at Denver, Aurora, 10; Yale University, New
Haven, Conn., 9; Cornell University,
New York, 7; and Baylor College of
Medicine, Houston, and University
of Bologna, Italy, with 5 each.
“The quality of the content exceeded our expectations,” said Dr. Coselli.
The Aortic Symposium takes the
year off in 2017, ceding the city of
Boston to the AATS Mitral Conclave,
scheduled for April 25-28.
MAY 14-18, 2016 • BALTIMORE CONVENTION CENTER
New Product Launches in
the Exhibit Hall
BioStable Science &
Engineering
Booth 676
New Product: HAART 300 Aortic Annuloplasty Device
Description: The HAART 300 Aortic Annuloplasty Device is the first internal geometric
annuloplasty ring to be developed for aortic
valve repair. The device received the CE mark
of approval in February of 2016. The device
is not currently available for sale in the United States.
CorMatrix®
Booth 128
CorMatrix® Cardiovascular, Inc. is a privately held medical device company dedicated
to developing and delivering innovative
biomaterial devices that harness the body’s
own innate ability to repair damaged cardiac and vascular tissues. CorMatrix® ECM®
Technology allows surgeons to restore the
native anatomy of cardiac and vascular tissue in need of repair, serving as a superior
alternative to synthetic or cross-linked materials. The Company is currently researching,
developing and commercializing a platform
technology known as CorMatrix® ECM®
for a variety of cardiovascular and other
indications. CorMatrix® has U.S. clearance
and European registration (with a CE Mark)
for its ECM® technology. Since its launch in
2006, CorMatrix® ECM® devices have been
used at more than 975 hospitals across the
U.S. and implanted in over 135,000 cardiac
procedures.
CorMatrix® Tyke™
CorMatrix® Tyke™ is intended for use in
neonates and infants for repair of pericardial
structures, as an epicardial covering for damaged or repaired cardiac structures, as a patch
material for intracardiac defects, septal defects
and annulus repair, suture-line buttressing,
and cardiac repair. Tyke™ is made of 2 layers
of CorMatrix® ECM® as compared to the 4
layers of the current CorMatrix® ECM® for
Cardiac Tissue Repair and therefore providing
a thinner product for smaller repairs.
CryoLife
Booth 457
On-X® Aortic® Heart Valve
The On-X® Aortic Heart Valve is designed to
minimize hemostasis and hemolysis, making
it the only mechanical valve that is safer
with less anticoagulation. FDA approved at
INR 1.5–2.0. after 3 months standard therapy.
Chord-X® Pre-Measured Loops
for Mitral Chordal Replacement
Simplifies Chordal Replacement with:
• Pre-configured loops system in most commonly used sizes: 12mm, 16mm, 20mm,
24mm
• ePTFE Suture
• Prosthesis features 3 chordal suture loops
and 1 suture pair for papillary muscle with
attached pledget
• Surgeon may choose to use all 3 loops, or
fewer. Removal of unwanted loops does not
compromise integrity of loop system
Honored Guest
Lecturer
Brian Kelly
Scanlan International,
Inc.
Booth 623
Southmedic Inc.
Booth 212
SCANLAN® Gonzalez-Rivas & Foerster Lung
Grasping Clamps and Dissectors, Khan Decortication Grasper, SCANLAN® Chitwood
DeBakey & Harken Clamps & Chitwood
Knot Pushers. SCANLAN® Reliance Bulldogs
& Applier, Yasargil Temporary Occlusion
Clips, Dennis DeBakey Clamps, SCANLAN®
V.I.P™ Metal Sterilization Tray
ProCell™ - The first medical device to automate surgical sponge-blood recovery for cell
salvage – eliminating hand-wringing.
Symmetry Surgical
Booth 403
Our Vesocclude™ product line includes safe
secure titanium clips, appliers with SureGrip™ technology and convenient patented
easy-to-use cartridges.
AATS thanks
the following
companies for
their support
EDUCATIONAL SUPPORT
Chord-X® Chordal Sizer
• Rotatable leaflet hook
• Automatic locking hooks for loop tying
• Single handed operation
• Color coded scale corresponds to Chord-X®
Pre-Measured Loops
• Leaflet hook design prevents loops from
slipping
9
Kelly is the 29th head
Bty ofrian
football coach at the UniversiNotre Dame. Currently the
third-winningest active coach in the
NCAA Football Bowl Subdivision,
Kelly has guided Notre Dame to
37 wins over his tenure. No Notre
Dame football coach has ever collected more victories over his first
four seasons.
Coach Kelly and his wife Paqui
play host to a series of events benefiting the Kelly Cares Foundation,
established by the couple to support
organizations, initiatives and programs that closely align with the
goals and values of the Kelly family
in personal involvement, with emphasis on breast cancer research,
prevention, education and awareness; education and institutional
advancement.
Coach Kelly will speak on Tuesday at 11:40 a.m.
Platinum Level $50,000 and higher
Siemens Medical Solutions
Medtronic
Gold Level $25,000 - $49,999
Edwards Lifesciences
Ethicon
Bronze Level $10,000 – $24,999
Abbott Vascular
Olympus America, Inc.
St. Jude Medical
MARKETING SUPPORT
Platinum Level $75,000 – $100,000
Medtronic
Gold Level $50,000 – $74,999
LivaNova
Silver Level $25,000 – $49,999
CryoLife
Zimmer Biomet
Bronze Level $14,000 – $24,999
Abbott Vascular
Atricure
JOMDD
St. Jude Medical
Corporate Level $0 – $13,999
Ethicon
Essential Pharmaceuticals
Medela
WSPH
10
2016 AATS Annual Meeting Exhibitors
A & E Medical Corporation
511
2310 S Miami Blvd., Suite 240, Durham, NC
27703
www.aemedical.com
A&E Medical products include MYO/Wire®
temporary pacing wires, MYO/Wire II sternum
wires, MYO/Punch rotating surgical punch,
MYO/Lead disposable patient cable and DoubleWire high strength sternal closure system.
American Association for Thoracic Surgery
May 15-17, 2016
Baltimore Convention Center
Exhibit Halls F, G and Swing
Abbott Vascular
502
3200 Lakeside Drive, Santa Clara, CA 95054
www.abbott.com
MitraClip is the world’s first transcatheter mitral valve repair therapy available, providing an
option for select patients with degenerative mitral
regurgitation.
LSI
Solution
471
Kapp
Surgical
371
LivaNova
447
Edwards
Lifesciences
435
AtriCure,
Inc
527
Admedus
411
WSPCHS
611
Surgitel
606
Medtronic, Inc
235
Acute Innovations
565
21421 NW Jacobson Road, Suite 700, Hillsboro, OR 97124
www.acuteinnovations.com
ACUTE Innovations®, a leader in thoracic and
trauma repair, introduces RibLoc® U Plus 90, a
low-profile instrumentation to use in conjunction
with the U Plus Chest Wall Plating System. The
U Plus 90 Instrumentation provides easy access
for sub-scapula and deep posterior fractures, and
offers a low-profile LED lighted contra-angle
handpiece that powers drilling and screw installation - all at your fingertips. Come by booth 565
to learn about the advancements in ACUTE’s
chest wall plating systems.
 Admedus
411
8400 Normandale Lake Blvd, Suite 920, Minneapolis, MN 55437
www.admedus.com
Admedus, a global healthcare group, is working
with renowned medical leaders to bring new
medical technologies to market. CardioCel®,
a cardiovascular scaffold, is the first of our
ADAPT® tissue engineered bio-implants and is
being used by surgeons to repair simple and complex cardiac defects.
All Star Recruiting
585
6119 Lyons Road, Coconut Creek, FL 33073
www.allstarrecruiting.com
All Star Recruiting matches top-quality cardiothoracic professionals with healthcare facilities
across the country. With years of incomparable
success in the industry, our specialized staff uses
a consultative, personal approach to quickly and
efficiently facilitate both permanent and temporary medical placement. For those looking to
advance their careers, please stop by and leverage
us as a resource!
AME Publishing Company
130
Building F10A, 2 Technology Place, Macquarie University, NSW 2109 Australia
www.annalscts.com
AME Publishing Company (www.amegroups.
com) was founded in 2009 as an international
publisher of medical journals and books. AME
has published more than 20 journals covering
a wide range of medical disciplines including
Annals of Cardiothoracic Surgery, Journal of
Thoracic Disease etc., 40 books and held more
than 100 conferences.
 AtriCure, Inc.
527
7555 Innovation Way, Mason, OH 45040
www.atricure.com
AtriCure is intent on reducing the global Afib
epidemic and healing the lives of those affected
through clinical science, education and innovation. We are a leading Afib solutions partner
with the only FDA-approved surgical treatment
for Afib and most widely implanted occlusion device for left atrial appendage management.
Continued on page 11
Bard Davol
157
100 Crossings Boulevard, Warwick,
RI 02886
www.davol.com
Bard is the market leader in comprehensive soft tissue reconstruction. In
addition to this extensive suite of
products, our BioSurgery franchise is
delivering a growing line of enhanced
sealants and hemostatic products to
complement surgical techniques across
thoracic, cardiovascular, and other
surgical specialties. This franchise is
committed to serving our surgeons
and clinicians by leveraging unique
& proprietary materials science and
continuing Bard’s focus on improving
clinical outcomes.
Baylis Medical
583
2645 Matheson Blvd. East Mississauga ON Canada L4W 5S4
www.baylismedical.com
Baylis Medical develops and markets
high-technology medical devices
used in the fields of interventional
cardiology and interventional radiology. Our vision is to develop and
market innovative medical therapies
while Improving the Lives of People
Around the World. Company has
offices in Montreal and Toronto
(Canada), Boston (USA), and London (UK).
BFW, Inc.
506
2307 River Road, #103, Louisville,
KY 40206
www.bfwinc.com
BFW is known as a worldwide technological leader in surgical illumination
and headlight video imaging. Visit our
booth to experience the foremost innovations in portable LED headlights
offering intense, clean and bright,
white light and our new Hatteras™
LED light source -- unmatched intense
fiberoptic illumination for headlights
and instrumentation.
BioStable Science &
Engineering
676
2621 Ridgepoint Drive, Suite 100
http://www.biostable-s-e.com/
BioStable Science & Engineering is
developing and commercializing proprietary valve repair technologies that
provide an alternative to valve replacement for aortic valve disease. The company’s HAART Aortic Annuloplasty
Devices are designed to simplify and
standardize aortic valve repair for
patients undergoing surgery for aortic
insufficiency or root aneurysm.
Bolton Medical Inc.
614
Austin, TX 78754
www.boltonmedical.com
Bolton Medical is a subsidiary of the
WerfenLife Company. WerfenLife is
a global company that manufactures
and distributes medical diagnostic
solutions and medical devices worldwide. Bolton’s vision is to become
the leading provider of endovascular
solutions for aortic disease. Bolton
develops, manufactures and distributes
innovative, high quality products solely focused on the aorta. www.boltonmedical.com
Bovie Medical Corporation
214
5115 Ulmerton Road, Clearwater,
FL 33760
boviemedical.com
Bovie’s transformational new J-Plasma® device offers unparalleled preci-
sion and safety, with remarkably low
thermal spread and versatility across
specialties. The 3-in-1 Ultimate®
Generator will be available for handson demonstration. Please visit Bovie
Medical® at Booth 214
CardiacAssist, Inc.
405
240 Alpha Drive, Pittsburgh, PA
15238
www.cardiacassist.com
CardiacAssist, doing business as TandemLife®, is the manufacturer of the
most versatile Extracorporeal Life Support Platform. The TandemHeart®
pump & controller can be combined
with our unique kits to support a
variety of procedures. TandemLife has
launched several new products since
PROTEK Duo®; stop by our booth to
learn more.
Cormatrix Cardiovascular, Inc. 128
1100 Old Ellis Road, Roswell, GA
30076
www.cormatrix.com
CorMatrix develops and delivers
implantable, biomaterial devices that
harness the body’s ability to repair
damaged cardiac and vascular structures.
CryoLife, Inc.
457
1655 Roberts Blvd NW., Kennesaw,
GA 30144
www.cryolife.com
CryoLife® is one of the world’s leading contemporary medical device
companies providing preserved human
cardiac and vascular tissues, surgical
adhesives and sealants, cardiac lasers
for treatment of refractory angina,
PhotoFix™ bovine pericardium patch,
and most recently, On-X® mechanical
heart valves. CryoLife® is committed
to partnering with academic training
programs and cardiac surgical societies.
CT Assist
521
P.O. Box 524, Philipi, WV 26416
www.CT-Assist.com
CT Assist is a provider of cost-effective cardiothoracic surgery advanced
practitioners and perfusionists that
deliver quality care. CT Assist employs only talented and experienced
PAs, NPs and Perfusionists to provide
workforce management solutions
from long-term to locum tenens and
vacation coverage.
CTS Net
312
633 N Saint Clair, Chicago, IL 60611
www.CTSNet.org
CTSNet.org is the most comprehensive, reliable, and largest resource
for cardiothoracic surgery education
and collaboration on the Internet.
CTSNet is an online community of
cardiothoracic surgery professionals,
specialty-dedicated associations, and
industry groups. A not-for-profit organization, CTSNet is jointly overseen
by STS, AATS, and EACTS.
CureVentions
376
2033 E. Warner Rd. Suite 102, Tempe, AZ 85284
www.cureventions.com
CureVentions creates innovations for
healing. Our CurVest – a thoracic
compression vest – promotes deeper
breathing, maintains incision stability, and aides in pain reduction,
leading to quicker mobilization after
cardiothoracic surgery. The CurVest
improves patient compliance by providing security and the confidence to
follow prescribed therapies and participate in their recovery.
Delacroix-Chevalier
465
217 Oakland Drive, Sycamore, IL
60178
www.medalliancesolutions.com
Prominent instrument manufacturer,
Delacroix Chevalier, offers an expansive range of highly innovative surgical instrumentation and retractors
since 1920. Devices are exclusively
available in the US from MED Alliance Solutions, LLC, an ISO 13485
certified medical device distributor,
and partner of Surge Cardiovascular
providing open heart surgery disposables worldwide.
De Soutter Medical USA
678
224 Rolling Hill Road, Suite 12A,
Mooresville, NC 28117
www.de-soutter.com
De Soutter Medical manufactures
the new SteruDrive Cardiothoracic
Saw. The SternuDrive is specifically
designed for cutting the sternum and
uses a unique “rudder control” system
to keep the cut on line. Utilizing the
latest technology including Lithium
ion batteries, the SternuDrive provides
a fast and accurate cut with minimal
noise and vibration.
Designs For Vision, Inc.
470
760 Koehler Avenue, Ronkonkoma,
NY 11779
www.designsforvision.com
Just See It™ with Designs for Vision’s
lightweight custom-made surgical
Telescopes - See It Even Better™
with the L.E.D. Daylite® or Twin
Beam®, L.E.D. Daylite® providing
the brightest and safest un-tethered
illumination. Introducing the L.E.D.
Daylite® Nano Cam HD video from
your prospective.
Dilon Technologies
12050 Jefferson Ave, Ste 340
Newport News VA 23606
307
EACTS
310
EACTS House, Madeira WalkWindsor, SL4 1EU, United Kingdom
www.eacts.org
EACTS is the largest European Association devoted to the practice of cardiothoracic surgery. The main objective
of the Association is to advance education in the field of cardio-thoracic
surgery and to promote, for the public
benefit, research into cardiovascular
and thoracic physiology and therapy
and to correlate and disseminate
the useful results thereof. Visit booth
124 for information on: membership,
future meetings and all activities of
EACTS. Journals: EJCTS (European Journal of Cardio-Thoracic
Surgery) ICVTS (Interactive Cardiovascular and Thoracic Surgery)
and MMCTS (Multimedia Manual
of Cardiothoracic Surgery).
 Edwards Lifesciences
435
One Edwards Way, Irvine, CA
92614
www.edwards.com
Edwards Lifesciences, based in Irvine,
Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care
and surgical monitoring. Driven by a
passion to help patients, the company
collaborates with the world’s leading
clinicians and researchers to address
unmet healthcare needs, working to
improve patient outcomes and enhance
lives. For more information, visit www.
Edwards.com and follow us on Twitter
at @EdwardsLifesci.
Elsevier Inc.
216
1600 JFK Blvd., Ste 1800, Philadelphia, PA 19103
www.elsevierclinicalsolutions.com
Elsevier is a world‐leading provider
of information solutions that enhance
the performance of science, health,
and technology professionals, empowering them to make better decisions,
deliver better care, and sometimes
make groundbreaking discoveries that
advance the boundaries of knowledge
and human progress. Elsevier provides
web‐based, digital solutions — among
them ScienceDirect, Scopus, Elsevier
Research Intelligence and ClinicalKey
— and publishes over 2,500 journals,
including The Lancet and Cell,
and more than 33,000 book titles,
including a number of iconic reference works. Elsevier is part of RELX
Group plc, a world‐leading provider of
information solutions for professional
customers across industries.
Enova Illumination
684
1839 Buerkle Road, St. Paul, MN
55110
www.enovaillumination.com
Enova makes the world’s brightest
LED Surgical Headlight, XLT-225 designed for thoracic surgery.
NEW – HD camera system that attaches to loupes or LED headlight. Records and live-streams HD video from
surgeon’s perspective. Save, store, and
share video recordings with colleagues
worldwide.
Essential Pharmaceuticals
680
100 Princeton South Corp. Center
Suite 140, Ewing, NJ 08628
www.essentialpharma.com
Essential Pharmaceuticals is devoted
to development and sales of pharmaceutical products in the transplant and
cardiothoracic surgery fields including
Custodiol® HTK organ preservation
solution. Originally developed for cardiac surgery, Custodiol® HTK offers
superior convenience with water like
viscosity and no need for additives or
filter.
ESTS
410
1 The Quadrant, Exeter, Devon,
EX2 4LE, United Kingdom
www.ests.org
ESTS is the largest international
general thoracic surgery organization
with over 1450 members from all
Continents. Our mission is to improve
quality in our specialty: from clinical
and surgical management of patients
to education, training and credentialing of thoracic surgeons worldwide.
ETHICON
121
4545 Creek Road Cincinnati, OH
45242
www.ethicon.com
Ethicon US LLC , brings to market
a broad range of innovative surgical
products, solutions and technologies
used to treat some of today’s most
prevalent medical issues, such as: colorectal and thoracic conditions, spine
and cardiovascular conditions, cancer,
obesity and other conditions requiring
general surgery. Learn more at www.
ethicon.com.
Fehling Surgical Instruments 503
509 Broadstone Lane, Acworth, GA
30101
11
www.fehlingsurgical.com
FEHLING SURGICAL INSTRUMENTS features Minimally Invasive
Valve Sets including NEW Retractor
designs for unmatched Atrial Exposure. Stop by and take our new MICS
Simulator for a spin to refine your
manual/tactile skills on a “Dummy”!
CERAMO® surface means high efficiency through enhanced performance,
increased endurance and minimal
maintenance.
G + N Medical
579
Stane Street, Slinfold, Horsham,
West Sussex, RH13 0GN
www.gandn.com
G+N Medical Inc., is a British based
developer and distributor of medical
devices. G+N will be exhibiting ThorAcc®, a simple non-invasive device to
facilitate uniform alignment of the divided sternum in Cardiac Surgery and
BracePlus™, a sternal support band
to assist patient recovery following
cardiothoracic surgery.
Genesee BioMedical, Inc.
477
700 West Mississippi Avenue, Denver, CO 80223-3408
www.geneseebiomedical.com
Design Beyond Standard. Genesee
BioMedical, Inc. provides unique
devices for cardiothoracic surgery
including sternal/thoracic valve
retractors for adult, adult congenital
and pediatric cardiac surgery, instruments for MICS, coronary graft
markers, suture guards, retraction
clips and aortic valve repair. Now
available “PHOTOFIX” Bovine
Pericardial Patch. Denver, CO USA
www.geneseebiomedical.com
Getinge Group
251
45 Barbour Pond Road, Wayne, NJ
07470
www.maquetusa.com
Getinge Group is a leading global
provider of products and systems that
contribute to quality enhancement and
cost efficiency within healthcare and
life sciences. We operate under the three
brands of ArjoHuntleigh, Getinge and
Maquet. ArjoHuntleigh focuses on patient mobility and wound management
solutions. Getinge provides solutions
for infection control within healthcare
and contamination prevention within
life sciences. Maquet specializes in
solutions, therapies and products for
surgical interventions, interventional
cardiology and intensive care.
Gore & Associates, Inc.
576
1505 N. Fourth Street, Flagstaff, AZ
86004
www.goremedical.com
At Gore, we have provided creative
therapeutic solutions to complex medical problems for more than 35 years.
During that time, more than 35 million
innovative Gore Medical Devices have
been implanted, saving and improving
the quality of lives worldwide. Our
extensive family of products includes
vascular grafts, endovascular and interventional devices, surgical meshes for
hernia and soft tissue reconstruction,
staple line reinforcement materials, and
sutures for use in vascular, cardiac, and
general surgery. We are one of a select
few companies to appear on all of the
US “100 Best Companies to Work For”
lists since the rankings debuted in 1984.
For more information, visit www.goremedical.com.
12
GUNZE Limited
677
2-10-4 Nihonbashi, Chuo-ku, Tokyo,
Japan 103-0027
www.gunze.co.jp/e/medical
Gunze is a leading Japanese manufacturer and seller of bioabsorbable
medical materials. Our diverse product
lineup ranges from tissue reinforcement materials to bone fixation
devices. By exhibiting PGA sheet
NEOVEIL, both CE and FDA certified
at AATS, we hope to deliver the best
patient outcomes in the thoracic field.
Heart Hugger
406
6489 Camden Ave, Suite 106, San
Jose, CA 95120
www.hearthugger.com
HEART HUGGER Sternum Support
Harness: Patient-controlled pain
management post-op. Heart Hugger
gives patients the confidence and security to be aggressive with RT, speeding recovery, while stabilizing their
wound. Patients squeeze the handles
together whenever they cough or move,
tightening the chest strap, supporting
the ribcage laterally with uniform encircling pressure.
Heart Valve Society
412
500 Cummings Center, Suite 4550,
Beverly, MA 01915
www.HeartValveSociety.org
“The Heart Team In Action”
The HVS has now held two successful
annual meetings in 2015 and 2016.
Whether you are a cardiologist, surgeon, researcher or another member
of the crucial valve disease treatment
team, the HVS welcomes you to become a part of something very unique.
Membership is available online at
www.heartvalvesociety.org/membership.
HeartWare, Inc
602
500 Old Connecticut Path, Framingham, MA 01701
www.heartware.com
At HeartWare, we are focused on
innovation and enhancing outcomes
in the treatment of end stage heart
failure. With the rising utilization of
the HVAD® System in the market, it
has quickly become the VAD of choice,
demonstrating high survival rates,
low complication rates and improved
quality of life.
International Society of Minimally
Invasive Cardiac Surgery
414
500 Cummings Center, Suite 4550,
Beverly, MA 01915
www.ismics.org
ISMICS: Innovation, Technologies,
and Techniques in Cardiothoracic and
Cardiovascular/Vascular Surgery.
2016 ISMICS Annual Scientific Meeting, 15-18 June 2016, Fairmont The
Queen Elizabeth, Montreal, Quebec,
Canada; www.ismics.org.
Intuitive Surgical, Inc.
257
1020 Kifer Road Sunnyvale, CA
94086
www.intuitivesurgical.com
Intuitive Surgical is the global leader
in minimally invasive, robotic-assisted
surgery. Its da Vinci® Surgical System – with a 3D-HD vision system
and EndoWrist® instrumentation –
enables surgeons to offer a minimally
invasive approach for a range of
complex procedures. da Vinci® is used
in more than 2,500 hospitals around
the world.
JACE Medical
142
987 College Ave. Winona Lake, IN
46590
www.jacemed.com
JACE Medical pioneered the world’s
first rigid sternal closure system
applied Pre Sternotomy; The Grand
Pre™. JACE Medical is a company
and culture committed to creating
innovative, transformational technologies that facilitate optimal patient
treatment, recovery and future wellness.
JOMDD
379
#601 Nihonbashi Life Science
Building, 2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023,
JAPAN
www.jomdd.com
JOMDD manufactures “Ozaki VRec
Sizer”, the proprietary device for performing Aortic Valve Neo-Cuspidization (OZAKI Procedure, AVNeo).
Initially invented by Prof. Shigeyuki
Ozaki in Japan, with 9 years and 1500
cases of follow-up data now, AVNeo
has been adopted to many prestigious
adult and pediatric heart centers in
the U.S. and Europe. J
 Kapp Surgical
Instrument Inc.
371
4919 Warrensville Center Road,
Cleveland, OH 44128
www.kappsurgical.com
Kapp Surgical is a custom design
shop which designs surgical instruments and implants, manufactures
them, and sells as well as distributes
domestically and internationally.
Kapp’s exclusive products are: The
Cosgrove Heart Retractor, Strip T’s
surgical organizer, and countless surgical devices all FDA approved with
several pending approvals.
Karl Storz
Endoscopy-America, Inc.
618
2151 E. Grand Ave., Suite 100, El
Segundo, CA 90245
www.karlstorz.com
KARL STORZ, a leader in endoscopic
technologies for over 70 years, offers
solutions for video-assisted thoracoscopic surgery. Our EndoCAMeleon®
Cardiothoracic Telescope allows
surgeons to adjust viewing direction
from 0° to 120°. And, combined
with our AUTOCON® II 400 HF
generator, RoBi® Grasping Forceps
and Scissors support a range of procedures.
KLS Martin, LP
365
PO Box 16369, Jacksonville, FL
32245
www.klsmartinnorthamerica.com
KLS Martin is a company dedicated to
providing innovative medical devices
and power systems for craniomaxillofacial surgery. The company’s
rich history began with surgical
instrument production in Tuttlingen,
Germany in 1896 and continued with
miniplate production in 1975. KLS
Martin has advanced the capabilities
of distraction osteogenesis, and revolutionized resorbable fixation with the
SonicWeld Rx system.
LifeNet Health
673
1864 Concert Dr. Virginia Beach,
VA 23453
www.lifenethealth.org
LifeNet Health helps save lives, restore
health, and give hope to thousands of
patients each year. We are the world’s
most trusted provider of transplant
solutions, from organ procurement
to new innovations in bio-implant
technologies and cellular therapies—a
leader in the field of regenerative
medicine, while always honoring the
donors and healthcare professionals
that allow the healing process.
 LivaNova
447
14401 W. 65th Way, Arvada, CO
80004
www.livanova.com
Perceval Aortic Pericardial Heart
Valve - With a reproducible technique
that leads to shorter procedures and
improved outcomes, Perceval optimizes
the surgical approach to aortic valve
replacement.
LoupeCam by VizVOCUS inc. 577
10245 E. Via Linda Blvd, Suite 210,
Scottsdale, AZ 85258
www.LoupeCam.com
The ProHD LoupeCam® takes visualization and HD video recording to
a complete different level. This nickel-size camera, with only 0.4 oz, offers
a 3.0 MP sensor, a built-in microphone
and HD video recording 1280x720p
directly to your laptop with full Mac
or Windows options. Mounting adapters available for all loupes models.
The Bluetooth Footpedals ensure a
complete hands-free experience. www.
LoupeCam.com
 LSI Solutions
471
7796 Victor-Mendon Rd., Victor NY
14564
www.lsisolutions.com
With 9 years of proven clinical results and over 2 million fasteners sold
worldwide, COR-KNOT® is suture
fastening technology you can trust.
COR-KNOT® reduces cardiopulmonary bypass and cross clamp time,
saving total operative time and improving patient outcomes. Visit our
Booth #471.
combination of transit time flow measurement (TTFM) and high frequency
ultrasound imaging guidance to help
reduce and minimize the risk of
negative postoperative outcomes, Medistim’s quality assessment technology
offers surgeons quantifiable validation
and guidance during cardiovascular,
vascular, transplantation and neurosurgery.
 Medtronic, Inc.
235
555 Long Wharf Drive | New Haven, CT 06511
www.medtronic.com
As a global leader in medical technology,
services and solutions, Medtronic improves the lives and health of millions of
people each year. We use our deep clinical, therapeutic and economic expertise
to address the complex challenges faced
by healthcare systems today. Let’s take
healthcare Further, Together. Learn more
at Medtronic.com.
Microsurgery Instruments, Inc. 613
PO Box 1378, Bellaire, TX 77402
www.microsurgeryusa.com
Microsurgery Instruments sells
surgical instruments and loupes
worldwide. Our Titanium surgical
instruments consist of scissors,
needle holders, forceps and surgical
sets. Loupes range from 2.5x to 11x
magnification.
MT Medi Corp.
279
2207-33 Wood Street, Toronto, ON
M4Y 2P8, Canada
www.mtmedi.com
We offer Exceptional Spring Style and
Double Action Titanium Scissors,
Forceps and Needle Holders with
Tungsten Carbide Inserts for Thoracic
and Cardan Surgery. We guarantee
20,000 cuts for our Titanium Scissors
and 5 years warranty for Titanium
Forceps and Titanium Needle Holders
with excellent grasping. Free of charge
Trial available.
Mallinckrodt Pharmaceuticals 144
675 McDonnell Blvd., St Louis, MO
63042
www.mallinckrodt.com
Mallinckrodt Pharmaceuticals is an
industry leader in providing specialty
biopharmaceutical products used in
the treatment of autoimmune and
rare disease specialty areas, respiratory therapies, pain and related conditions, and diagnostic procedures. The
company’s three segments include
branded medicines and devices,
generic drugs and medical imaging.
Visit www.mallinckrodt.com to learn
more.
Munson Healthcare
622
1105 Sixth Street, Traverse City, MI
49684
www.munsonhealthcare.org
Munson Healthcare is a network
of nine hospitals that serves 30
counties in northern Michigan. The
system of nationally recognized
hospitals includes a major tertiary
referral medical center and Level I
Trauma Center. Munson Healthcare’s hospitals have advanced and
sophisticated technology, and employ
more than 1,000 physicians representing 63 specialties.
Medela, Inc.
615
1101 Corporate Drive, McHenry,
IL 60050
www.medela.com
Medela, the market leader in breast
feeding education and research,
provides medical vacuum solutions
featuring Swiss technology in over 90
countries. Medela Healthcare optimizes patient care through pioneering and
intelligent, mobile, digital chest drainage therapy and advanced wound
management with NPWT solutions
that promotes patient mobility while
offering clinical flexibility.
Myriad Genetic Laboratories 271
320 Wakara Way, Salt Lake City, UT
84108
www.myriad.com
Myriad myPlan Lung Cancer is a
46-gene expression signature based
on Cell cycle progression (CCP)
genes, which identifies a patient’s
actual risk of dying from lung cancer within 5-years. Tumors with a
higher myPlan Lung Cancer prognostic score are more aggressive and
carry a higher lung cancer specific
mortality rate than tumors with a
lower score.
Medistim
135
14000 25th Ave. N. Ste. 108, Plymouth, MN 55447
www.medistim.com
Medistim is the standard of care in
the operating room. With the unique
NeoChord, Inc.
670
5402 Parkdale Drive, Suite 160, St.
Louis Park, MN 55416
www.neochord.com
Based in St. Louis Park, Minnesota,
NeoChord is a privately held medi-
cal technology company leading the
advancement of minimally invasive,
beating heart repair of degenerative
mitral valve regurgitation. NeoChord
received CE market clearance in December 2012 for the DS1000 system
and has successfully treated over 350
patients to date.
Olympus America Inc.
250
3500 Corporate Parkway, POB 610
Center Valley, PA 18034-0610
Orascoptic
305
3225 Deming Way #190, Middleton, WI 53562
www.orascoptic.com
Orascoptic has been designing and
manufacturing award-winning
loupes, lights and operator chairs for
surgeons, dentists, and hygienists
for more than 30 years. The Orascoptic focus is superior visualization
coupled with optimal clinical ergonomics. We are recognized as the innovators in the market, being the first
company to bring you a portable LED
light, the first loupe with a built-in
cable-less headlight, and the first
loupe with adjustable magnification
(zom) power.
Osborn Medical Corporation 211
7022 S. Revere Pkwy, Suite 240
Centennial CO 80112
Otto Trading, Inc.
303
1921 Carengie Ave Suite C., Santa
Ana, CA 92705
Manufacturer and distributor of
portable drug-free pain management
technology, TENs and EMS.
Posthorax Inc
277
1268 Jackson Road, Clearwater, FL
33755
The newly designed Posthorax Sternum Support vest, clinically proven
to reduce a patients pain, prevent
atelectasis, mechanical complications and re-admissions. With our
patented design we have conducted
9 clinical trials in 6 countries with
more than 8500 patients. Please come
by our booth to see this new standard
of care.
Qualiteam s.r.l.
210
Casale Nassio Sopra 15A, Chiaverano, TO, 10010, Italy
www.qualiteam.com
Qualiteam designs products to improve
postoperative recovery. Our dual-functional sternum and breast supports
are unlike any other. They comfortably
protect the internal closure from the
outside day and night and effectively
assist the healing sternum to decrease
sternal infections, pain and pulmonary complications which ultimately
decreases health care costs.
Quest Medical Inc.
429
One Allentown Pkwy., Allen, TX
75002
www.questmedical.com
Quest Medical, Inc. is a medical
device manufacturer and worldwide
distributor specializing in protecting
the heart during cardiac surgery with
the Quest MPS 2® and Microplegia.
Quest also offers a unique variety of
aortic punches, safety valves, vascular loops, and an anesthesia line
designed for optimum cardiovascular
surgery.
Redax S.p.A.
215
18, Poggio Rusco, Italy, 46025
www.redax.it
Redax developed a complete range of
chest drains with innovative design
aimed at containing dimensions, allowing for additional stability. Chest
Drains are available in different models also with a portable vacuum unit
for easier portability and early mobilization of patients. Percutaneous Centesis Kit and Fluted Silicone Drains
belong to the cardio-thoracic range of
products too
rEVO Biologics
682
175 Crossing Blvd. | Framingham,
MA 01702
www.revobiologics.com
rEVO Biologics, Inc. is a commercial-stage biopharmaceutical company
focused on the development and commercialization of specialty therapeutics to address unmet medical needs
in patients with rare, life-threatening
conditions. The company’s lead product, ATryn, is the first and only plasma-free antithrombin concentrate.
RTI Surgical Inc.
402
9600 Great Hills Trail, Suite #160E,
Austin, TX 78759
www.rtisurgical.com
RTI Surgical is a leading global
surgical implant company providing
surgeons with safe biologic, metal and
synthetic implants. RTI’s implants
are used in sports medicine, general
surgery, spine, orthopedic, trauma
and cardiothoracic procedures and are
distributed in nearly 50 countries. RTI
is headquartered in Alachua, Fla., and
has four manufacturing facilities in
the U.S. and Europe.
Rultract/Pemco Inc.
476
5663 Brecksville Road, Cleveland,
OH 44131-1593
www.pemcomed.com
Since 1955, Pemco has designed and
manufactured precision surgical
instruments for the cardiovascular
field. Products include Rultract Skykook Retractor, reusable Subclavian
and Femoral Cannula and Anesthesia
Screens. Pemco has documented that
Perfusion Cannula, Coronary Ostial
Cannula and Cardiac Suckers offer
significant cost savings over disposables.
Scanlan International, Inc.
623
One Scanlan Plaza, St. Paul, MN
55107
www.scanlaninternational.com
Highest quality surgical products
designed and manufactured by the
Scanlan family since 1921. Over 3000
titanium and stainless steel precision
instruments including: VATS/MIS
thoracoscopic instruments, Scanlan®
SUPER CUT™ Scissors, and Scanlan® LEGACY titanium needle holders
and forceps. Single-use products include Aorta/Vein Punches, Scanlan®
VASCU-STATT® bulldog clamps and
graft markers.
Siemens Healthcare
265
40 Liberty Blvd , Mail Code 40-3E,
Malvern, PA 19355
www.healthcare.siemens.com
Siemens Healthcare helps providers
meet clinical, operational and financial challenges. A global leader in
medical imaging, laboratory diagnostics and IT, we understand the entire
care continuum—from prevention and
early detection to diagnosis and treatment. For more: usa.siemens.com/
healthcare
Sontec Instruments Inc.
513
7248 South Tucson Way, Centennial, CO 80112
www.SontecInstruments.com
Sontec offers a comprehensive selection of exceptional hand held
surgical instruments, headlights and
loupes available to the discriminating surgeon. There is no substitute
for quality, expertise and individualized service. Sontec’s vast array
awaits your consideration at our
booth.
Southmedic
212
50 Alliance Blvd. Barrie, Ontario,
Canada, L4M 5K3
www.southmedic.com
Southmedic Incorporated is a private,
Certified Woman-Owned manufacturer, distributor and supplier of medical
devices. Since 1983 Southmedic has
offered a wide range of medical devices such as surgical blades & safety
scalpels, Dynamic Tissue Systems™,
OxyMask™ and other respiratory
products to hospitals and clinics across
the globe.
St. Jude Medical, Inc.
327
6300 Bee Caves Rd., Austin, TX
78746
www.sjm.com
St. Jude Medical is a leading global
medical device manufacturer and is
dedicated to transforming the treatment
of some of the world’s most expensive
epidemic diseases. The company has
five major areas of focus that include
heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm
management, and cardiovascular diseases. Visit sjm.com.
Society of Thoracic Surgeons 311
www.sts.org
STS represents 7,100+ cardiothoracic surgeons, researchers, and allied
healthcare professionals worldwide
who are dedicated to improving the
lives of patients with cardiothoracic
diseases. STS offers benefits, including
participation in the renowned STS
National Database, subscriptions to
The Annals of Thoracic Surgery,
clinical practice guidelines, dynamic
educational offerings, and patient
resources.
STS Advocacy Center
314
20 F. St. NW, Washington, DC
20001
www.sts.org
Visit us in booth #314 and receive
timely information on federal legislative and regulatory initiatives
impacting the specialty, obtain tools
to engage members of Congress, and
become a Key Contact for your district.
STS members also can contribute to
STS-PAC and support champions of
cardiothoracic surgery in Congress.
Sunoptic Technologies
519
6018 Bowdendale Ave. Jacksonville,
FL 32216
www.sunoptictech.com
Our unique Titan-HD-Headlight-Camera enables true HD recording from the surgeon’s point-of-view.
Unobstructed video is captured on our
state-of-the-art Documentation System. Our new Titan X450 light source
has digital controls and on-board-filters for ease-of-use and long durability.
A 400w Xenon light sourse, the X450
provides unparalleled brightest for
deep-cavity visualization.
geons. The mission of TSF is to foster
the development of surgeon scientists
in cardiothoracic surgery; increasing
knowledge and innovation to benefit
patient care.
 Surgitel/General
Scientific Corp
606
77 Enterprise Drive, Ann Arbor, MI
48103
www.surgitel.com
SurgiTel is the manufacturer of premium loupes and headlights sold around
the world from their headquarters
in Ann Arbor Michigan. Holding a
variety of patents SurgiTel is always
on the forefront of Vision and Ergonomics.
Transonic Systems Inc.
671
34 Dutch Mill Rd., Ithaca, NY 14850
www.transonic.com
For 33 years, Transonic’s devices have
been used to provide quantitative flow
measurements during CABG, ECMO
& CPB. The AureFlo® System offers
patency assurance during CABG procedures. ELSA®, Transonic’s newest
system, is a breakthrough device to
help quantify oxygenator clotting,
measure VV recirculation and verify
flows during ECMO procedures.
Symmetry Surgical
403
3034 Owen Drive, Antioch, TN
37103
www.symmetrysurgical.com
Symmetry Surgical is dedicated to developing and delivering high-quality,
innovative surgical instruments that
meet clinicians’ needs and improve
patients’ lives. Our rich and diverse
history creates one of the industry’s
most comprehensive surgical instrument portfolios, which includes
our well-known brands. As part of
our broad cardiovascular – thoracic
portfolio, our Vesocclude™ product
line includes safe, secure titanium
clips, appliers with SureGrip™ technology and convenient, easy-to-use
cartridges.
SynCardia Systems, Inc.
619
1992 E Silverlake Drive, Tucson,
AZ 85713
www.syncardia.com
The SynCardia temporary Total Artificial Heart (TAH-t) is the world’s
only FDA, Health Canada and CE
approved Total Artificial Heart. It is
approved as a bridge to transplant for
patients dying from end-stage biventricular failure. Visit our booth for
updates on the 50cc TAH-t and destination therapy.
Terumo Cardiovascular Group 419
6200 Jackson Road, Ann Arbor, MI
48103
www.terumo-cvs.com
At Terumo Cardiovascular Group, we
develop, manufacture, and distribute
medical devices for cardiac and vascular surgery with an emphasis on
cardiopulmonary bypass, intra-operative monitoring and vascular grafting.
Through collaboration with clinicians
worldwide, we work to solve problems,
streamline processes, reduce costs,
and improve patient outcomes in the
cardiac OR
Thoramet Surgical Products
407
301 Route 17 N, Suite 800, Rutherford, NJ 07070
www.thoramet.net
The Surgeon’s choice for VATS instrumentation! We offer the most
comprehensive catalog of pure thorascopic patterns available. The feel
you want, the actuation you need,
the patterns you demand! Come visit
us at Booth 407 during the 2016
Annual Meeting to see and feel our
unique versatility!
Thoracic Surgery Foundation 315
TSF was first established in 1988 as
a 501(c)(3) not-for-profit charitable
organization. TSF is the charitable
arm of The Society of Thoracic Sur-
Ultralight Optics, Inc.
153
3505 Cadillac Ave Bldg H, Costa
Mesa, CA 92626
http://ultralightoptics.com/
The Featherlight is the top-rated LED
winner of Dental Town, Dental Adviser and rated 100% in Clinician’s
Report. Designed by dentist and
ophthalmologists, the focused light
illuminates the oral cavity perfectly,
distributing a balanced amount of
brightness that is comfortable for the
eyes in 6 different intensity levels.
There are over 100 custom-made
attachments for the light to fit onto
every pair of loupes, safety glasses,
headbands, prescription glasses, everything! With the option of having
a touch-sensor battery, you can work
absolutely hands-free, contamination-free with a system that works
for you.
Vikon Surgical
581
2719 19th Street S Homewood, AL
35209
www.vikonsurgical.com
Vitalcor, Inc.
610
100 E. Chestnut Avenue, Westmont,
IL 60559
www.vitalcor.com
Latex Free Coronary Artery Balloon
Cannulae with self-inflating Balloon
(3-year shelf life). Reusable Bulldog
Clamps. Axiom Wound Drains. Titanium and stainless steel specialty
instruments and retractors. Reusable
stabilizer for Beating Heart Surgery
and Mitral Valve Retractor.
Vitalitec
141
10 Cordage Park Circle, 200 Plymouth, MA, 02360
www.vitalitecusa.com
Vitalitec, a wholly owned subsidiary
of The Peters Surgical Group, will
be promoting their range of Peters
CV Sutures;Vitalitec Ligation Clip
Systems; IntrackÒ Atraumatic and
CygentÒ Flexible Clamps and Inserts,Enclose II Anastomosis Assist
Device; as well as GreyhoundTM,
NovaclipTM and SofiaTM disposable
bulldogs. The GeisterÒ Innovative
Retractor Systems and ValveGateÒ
MIS CV instrumentation will also be
on display.
Wexler Surgical
127
11333 Chimney Rock Road Suite
#110, Houston, TX 77035
www.wexlersurgical.com
Wexler Surgical designs and manufactures a variety of titanium and stainless steel specialty surgical instruments
and products for Cardiac, Vascular,
Thoracic, and Micro Surgery. Come
see our VATS/MICS instruments and
13
ask about our Optimus Series. Visit us
online at www.wexlersurgical.com for
more information about our products
and the services.
Wolters Kluwer Health
377
2001 Market Street, Philadelphia,
PA 19103
www.wolterskluwerhealth.com
Wolters Kluwer is a leading publisher of medical, health, and science
publications. We offer an extensive
selection of medical books, journals,
and electronic media for health professionals and students. Please visit
booth 377 to browse our comprehensive product line.
 WSPCHS
611
2300 Tupper Street Room C8-29,
Montreal, QC, h3h1p3, Canada
www.wspch.org
The mission of the World Society for
Pediatric and Congenital Heart Surgery is to promote the highest quality
comprehensive cardiac care to all patients with congenital heart disease,
from the fetus to the adult, regardless
of the patient’s economic means,
with an emphasis on excellence in
teaching, research and community
service.
Xenosys Co., LTD
523
2 Venture Ro, 100 Beong Gil, Yeonsu-ou Incheon, South Korea,
www.xenosys.co.kr
Xenosys is specialized in surgical telescope, surgical LED light, and surgical
camera system with wifi connection
available.
Zimmer Biomet
165
1520 Tradeport Drive, Jacksonville,
FL 32218
www.zimmerbiomet.com
Founded in 1927 and headquartered
in Warsaw, Indiana, Zimmer Biomet
is a global leader in usculoskeletal
healthcare. We design, manufacture
and market a comprehensive portfolio
of innovative Thoracic products and
treatment solutions for surgeons and
patients including, the RibFix™ Blu
Thoracic Fixation System, the SternaLock® Blu Primary Closure System
and SternaLock® 360 for patients with
poor bone.
Zimmer Biomet –
rejuvesol Solution
571
P.O. Box 708 Warsaw, IN 06580
www.zimmerbiomet.com
Founded in 1927 and headquartered
in Warsaw, Indiana, Zimmer Biomet
is a global leader in musculoskeletal
healthcare. We design, manufacture
and market orthopaedic reconstructive products; sports medicine,
biologics, extremities and trauma
products; spine, bone healing, craniomaxillofacial and thoracic products;
dental implants; and related surgical
products.
ZipperBelt.com
248
3419 Westminster #276, Dallas, TX
75205
The zipper belt Brace was developed
for patients who are now zipper club
members. Transient events such as
coughing or sneezing or even pushing
up from a chair can be very painful.
The zipper belt is a brace that the
patient can wear and at a moments
notice can get relief from a violent
sneeze or cough instead of just squeezing a pillow.
14
Graham Foundation: Honoring our Mentors Fellowship Program
I
n 2013, the AATS Graham Foundation established the “Honoring Our
Mentors” Fellowship Program to
pay tribute to eminent cardiothoracic and thoracic surgeons. The named
fellowships recognize the longstanding leadership and dedication
that these individuals
displayed throughout
their careers, in both
clinical practice and
in their commitment
to training the future generation of
CT surgeons. The
F. Griffith Pearson
Fellowship was the
inaugural fellowship
in 2013, followed by
the Marc R. de Leval
Fellowship. This year,
the Foundation is pleased
to offer two new fellowships
in honor of Lawrence H. Cohn and
Denton A. Cooley.
The Lawrence H. Cohn
Clinical Scholar Program
In making the announcement,
Dr. David Sugarbaker and Dr.
David Adams noted, “Our
mentor, teacher, and friend Dr.
Lawrence Cohn passed away in
February, leaving behind a legacy
of excellence in cardiothoracic
surgery that will be preserved
for generations through all of us.
Many have expressed an interest
to honor and remember this great
man; after careful thought, we have
established the Lawrence Cohn
Clinical Scholar program under
the aegis of the Honoring our
Mentors Fellowship program.”
To date, the Foundation has received over $300,000 in cash and
pledge commitments from individual
donors and Edwards Lifesciences
Foundation, which agreed to match
up to $75,000 in contributions received prior to this year’s AATS Annual Meeting.
The Lawrence H. Cohn Clinical
Scholar Program will provide $10,000
annually to facilitate advanced training in the management of patients
with valvular heart disease. A community service component will be integrated to help the awardees better
understand the needs of underserved
patients and to encourage additional
philanthropy.
“Dr. Cohn’s greatest attribute, and
what was most important to him,
was teaching each of us how to operate and how to take complete accountability for patients,” concluded
Drs. Sugarbaker and Adams.
The Denton A. Cooley Fellowship
Spearheaded by Dr. David Ott
from Texas Heart Institute/St.
Luke’s, The Cooley Hands Society has
established the Denton A. Cooley
Fellowship in CT Surgery. Dr. Ott’s
efforts have raised $200,000.
The funds will provide
$5,000 in annual support
to a cardiothoracic surgery resident or young
postgraduate surgeon to spend time
observing surgery
at the Texas Heart
Institute and Baylor
St. Luke’s Medical
Center.
“No doubt, we all
consider Dr. Cooley
to be one of the single,
greatest influences in our
lives and careers. He frequently
says that founding the Texas Heart
Institute and specifically its school
of surgery is the greatest achievement of his career,” noted Dr. Ott.
“As a select group of surgeons in
whom he invested his time and
talent, Cooley Hands now has this
opportunity to lead the country in
honoring him.”
The Marc R. de Leval Fellowship
For over 40 years, Marc de
Leval has practiced pediatric
cardiothoracic surgery in London.
Throughout his career, he has
maintained a close association with
AATS, starting with his time as a
Graham Traveling Fellow. In Dr.
de Leval’s honor, Dr. J. William
Gaynor, along with founding
members Edward L. Bove, MD,
Vaughn A. Starnes, MD, and Victor
Tsang, MD, initiated the proposal
for the fellowship to provide
funding for North American
surgeons to receive specialized
training at international congenital
heart surgery centers. “The
exposure to international cardiac
surgery allows us to build bonds
of friendship and collaboration
that endure to this day.
Unfortunately, under the current
training guidelines, this type of
international exposure is no longer
common,” noted Dr. Gaynor.
The Fellowship will provide young
North American trainees and early
career congenital heart surgeons
an opportunity to spend four to
six weeks studying congenital CT
surgery techniques at UK/European institutions. “We’ve raised over
$131,000 in cash and pledges and
we hope to raise additional funds to
increase the duration of the fellowship,” said Dr. Gaynor
.
The F. Griffith Pearson Fellowship
The Pearson Fellowship recognizes F.
Griffith Pearson, one of the fathers
of modern tracheal surgery and
the recipient of this year’s AATS
Lifetime Achievement Award. Dr.
Pearson introduced mediastinoscopy
to North America in the early 1960s
and demonstrated the importance
of mediastinal staging for lung
cancer, which led to a more rational
approach to the diagnosis, staging
and treatment of the disease. During
retirement, Pearson continued to
pioneer as a “surgeon in residence” in
Boston and Pittsburgh. Many say that
his greatest contribution to thoracic
surgery over 50+ years has been his
influence on generations of young
surgeons who have become thoracic
surgery leaders around the world.
The Pearson Fellowship supports
surgeons who have finished their residencies to advance their clinical thoracic techniques at a North American host
institute. Each fellow can spend four to
six weeks training at the host facility.
The “Honoring Our Mentors”
Fellowship Program is investing
in the next generation of CT surgeons. “We are indebted to those
mentees who have contributed
to these programs, publically acknowledging their gratitude to the
mentor who shaped their cardiothoracic surgery career,” noted Dr.
Sugarbaker.
Learn more about how you can
invest in the future by supporting
one of these fellowships by visiting
the Graham website: www.grahamfoundation.org or stop by the AATS
Welcome Center.
Last year, the AATS Graham Foundation achieved a milestone.
Thanks to the support of our individual donors, institutional and foundation contributors, and industry partners, we provided research and
fellowship opportunities to 134 surgeons and medical students from five
continents.
We thank our industry sponsors and organizational supporters who
have given so generously over the years.
Platinum Sponsor
$1,000,000 and above
American Association for Thoracic Surgery
Gold Sponsor
$500,000-$999,999
Silver Sponsors
$100,000-$499,999
Atricure
Ethicon
Ethicon China
Intuitive Surgical
Medtronic
Bronze Sponsors
up to $99,999
Anonymous
Boston Children’s Hospital
The Children’s Hospital of Philadelphia
CHI St. Luke’s Health
Cleveland Clinic
Cryolife
Keck Medical Center of USC
LivaNova
Olympus
St. Jude Medical
University of Michigan Medical School Department of Cardiac Surgery
University of Ottawa Heart Institute
If you wish to become one of our distinguished partners, please contact
Luiza Pellerin, Development Officer, lpellerin@aats.org.
15
Seeking Technical Perfection in
Congenital Heart Surgery
S
aturday’s Congenital Heart Disease Skills
Course focused on developing technical perfection in these complex and unique operations, in part through a focus on the value of the
latest imaging technologies in prepping, performing, and assessing surgery. The course was developed and moderated by Chair, E. Dean McKenzie,
MD, Texas Children’s Hospital, Houston, and
co-Chair, Krishna S. Iyer, MD, Fortis Escorts Heart
Institute, New Delhi.
As an example of the importance of imaging
technology, Gerald Ross Marx, MD, Boston Children’s Hospital, focused on the use of echocardio-
Gerald Ross Marx, MD, discussed the role of
echocardiography in evaluation of the mitral valve.
graphic evaluation of the mitral valve. Dr. Marx
discussed how the new technology is revolutionizing preoperative planning and assessment during
and after surgery by allowing surgeons to look at
all segments individually in real or nearly real time,
even in the operating room, and with the combination of anatomic and color-flow imaging, could
allow assessment of results immediately.
Of particular importance, he said, are current
and developing guidelines on this technology,
which seek to create uniform standards for presenting and discussing 3-D echocardiographic images
with surgeons, to allow the most accurate, rapid,
and interpretable images. Coupled with the phenomenal detail and viewing options possible with
3-D echocardiography, “most importantly, pediatric
cardiologists are seeking to share with the surgeons
better imaging, displays, orientation, and a better
nomenclature to improve our communication.”
Focusing on mitral valve repair techniques in
small children, Pedro J. del Nido, MD, Boston
Children’s Hospital, addressed a number of critical
issues vital to success.
Congenital mitral valve problems in children are
very different from those in adults, according to Dr.
del Nido. Most of the time in adults “it’s annulus
and leaflets, maybe a few cords, pretty straightforward, but in congenital, it’s always complicated.” He
detailed the three levels you need to worry about:
Pedro del Nido, MD, pointed out the special features
of mitral valve repair in small children.
supra-annular, annular, and subvalvular pathology.
Of particular concern is the enormous problem
of excess tissue growth that can occur at each level, and the tethering that can occur beneath the
valve, causing extreme rigidity and problems until
each component is addressed and the excess tissue/cords removed.
Other presentations focused on the mitral valve
and issues such as the use and importance of cerebral perfusion, repair of ventricular septal defects
and arch defects, dealing with Ebstein’s anomaly,
and technical refinement of hypoplastic left heart
syndrome (HLHS) treatment.
16
New Techniques and Technologies Flourish
in General Thoracic Surgery
S
aturday’s “Mastering Cutting-edge Technologies” General
Thoracic Skills course was presented by chair Mark Onaitis, MD,
Duke University, Durham, N.C., and
co-chair Haiquan S. Chen, MD, Fudan
University Shanghai Cancer Center.
David R. Jones, MD, of Memorial
Sloan Kettering Cancer Center, New
York, demonstrated with a number of
video presentations that video-assisted
thoracoscopic surgery (VATS) mediastinal lymphadenectomy is a highly
doable technique and stressed its
importance. “I do a complete lymphadenectomy in every case unless it’s a
known AIS [in situ] or MIA-type [minimally invasive] adenocarcinoma,” said
Dr. Jones. “It’s very easy if you get the
exposure and understand the anatomic boundaries,” he added.
M. Blair Marshall, MD, of Georgetown University, Washington, highlighted that VATS sleeve resection is
a minimally invasive technique with
considerable utility. “The benefits
can be adopted for
progressively more
complicated thoracic procedures,”
said Dr. Marshall.
To demonstrate, she
reviewed her own
work on how she progressed from hybrid
approaches to pure
VATS, focusing on patient selection issues,
Haiquan S. Chen, MD, spoke
instrumentation, port David R. Jones, MD, reviewed M. Blair Marshall, MD, talked
the feasibility of VATS.
about VATS sleeve resection.
on lung GGO lesions.
placement, and management strategies.
Dr. Marshall discussed cases includof pathological specimens detected
Furthermore, data support that subloing VATS distal tracheal right upper
more than one pulmonary carcinoma bar resection of single lesions presentlobe sleeve resection, VATS pulmonary after surgery, adding that this probing as GGOs is adequate.
artery and bronchial double sleeve
lem of multiple lesions is likely to
“It is reasonable to suggest that
resection, and VATS right upper lobe
become a common event with the
limited resection of multiple GGOs
sleeve resection in an octogenarian.
increasingly widespread application
should be performed. This is supportSynchronous non–small cell lung
of CT scanning.
ed by the good outcomes of limited
cancers are fairly common, making up
There is a growing body of data that resection for single GGO lesions, and
to 3.7%-8.0% of all NSCLCs in clinical demonstrates excellent survival after
the need to preserve lung parenchypractice, according to Dr. Chen.
resection of small solitary ground-glass ma when patients present with multiDr. Chen discussed how 24.6%
opacity (GGO) lesions, said Dr. Chen.
ple lesions,” Dr. Chen concluded.
Collaborative Efforts Yield an Excellent Interprofessional
Cardiothoracic Team Symposium
he Interprofessional Cardiothoracic Team SymToration
posium held on Saturday was a special collabbetween AATS and the American Society
of Extracorporeal Technology and the Association
of Physician Assistants in Cardiovascular Surgery.
Chaired by Gosta B. Pettersson, MD, and Katherine J. Hoercher, MD, both of the Cleveland Clinic,
the symposium focused on the goal of advancing
excellence in systems of care and outcomes.
Robert M. Sade, MD, of the Medical University
of South Carolina, discussed the nature of informed
consent for cardiovascular surgery, focusing on
whether it is achievable and what it should include.
“True informed consent is possible,” said Dr.
Sade. “The information is important, but far more
important is that the patient and the patient’s
family understand
the information.
We should provide
information and
not data – not too
much, but not too
little, just the right
amount for this
particular patient.”
Marci Damiano,
MD, of Washington University, St.
Louis, faced the
Robert M. Sade, MD, talked
difficult task of
about informed consent.
talking about the
definition of futility and when and
how surgeons need to say “no” to
the patient, the family, and even to
the referring physician. She focused
on the experiences that she and
her colleagues had as part of their
TAVR program.
“Our conversations with the
patient and the family are honest
conversations. We try to be attentive
and listen to what they have to say.
Marci Damiano, MD, addressed
Kamal R. Khabbaz, MD, spoke
We offer the patient and the family
when to say ‘no’ to patients.
on the nature and risk of PICS.
a meeting with multiple members
of the family so they can come to
grips with what the team has decided
later; 30%-80% have cognitive impairment and
would be the best recommendation for that patient.
they may not return to their pre-ICU level of cogBe compassionate and listen,” Dr. Damiano stressed.
nition; 10%-50% of patients experience depression,
The term Post Intensive Care Syndrome (PICS)
anxiety, PTSD, and sleep disturbance; and 33% of
was coined in 2010 at a task force meeting of the
family members have symptoms of depression and
Society of Critical Care Medicine, according to
PTSD and 70% have symptoms of anxiety.
Kamal R. Khabbaz, MD, Beth Israel Deaconess
He stressed that PICS treatment focuses on
Medical Center, Boston. Dr. Khabbaz discussed the maximizing mobility, minimizing delirium, and
nature, risks, and outcomes of PICS in both paenhancing coping skills through interventions that
tients and their families.
are carried out both in the ICU and after, as well as
The problems involved in PICS are extensive,
post-hospitalization.
said Dr. Khabbaz. For example, following an ICU
“Managing mental health in PICS requires setting
stay, 1-year mortality rates range from 26% to 63%; realistic expectations in both patients and families,
85%-95% of patients with ICU-acquired weakness- especially using tools, including websites, brochures,
es have symptoms that persist for 2-5 years; 50%and education about depression, anxiety, and
70% have difficulty with activities of daily living
PTSD,” said Dr. Khabbaz. “It is especially important
and instrumental activities of daily living 1 year
to encourage family involvement.”
18
I
AATS/STS General Thoracic Surgery Symposium
n Sunday’s AATS/STS General
Thoracic Surgery Symposium, chair
Thomas K. Waddell, MD, of the
University of Toronto, and co-chair
Paul E. van Schil, MD, University
Hospital of Antwerp (Belgium), oversaw a wide variety of talks under the
theme “The Best Way to Predict the
Future is to Invent it.”
Among the presentations, Cameron D. Wright, MD, Massachusetts
General Hospital, Boston, discussed
the management of post-intubation
tracheal stenosis, a condition that is
too often misdiagnosed as new-onset
“asthma.” He stressed the importance of using CT diagnosis and of
paying close attention to length in
determining treatment. For example,
the choice of the use of tubes, stents,
or a resection plus anastomosis can
be very much dependent on the
length of the stenosis. In addition,
it is extremely important in doing a
resection to be aware of the tension
that will result upon anastomosis,
which is one of the important causes
of failure, Dr. Wright said.
ECMO has dramatically improved
in the modern era, becoming essentially equivalent to other methods
of bridging to transplant in terms
Cameron D. Wright, MD, spoke on
post-intubation trachael stenosis.
R. Duane Davis, Jr., MD, reviewed the
evolution of ECMO technology.
Laura Donahoe, MD, discussed options
for treating thromboendarterectomy.
of mortality in select patients, according to R. Duane Davis, Jr., MD,
Florida Hospital, Orlando. The
technology has evolved at all levels,
including better membranes, better
cannulas, and better pumps. The
emphasis has moved from a focus on
salvage to support, with new ECMO
modes allowing patient ambulation
and longer-term treatment. One important ethical concern with ECMO
remains, however, as it is still not
a destination therapy and at some
point the patient must actively discontinue treatment.
Laura Donahoe, MD, of Toronto
General Hospital discussed the indications and outcomes of pulmonary
thromboendarterectomy, replacing
Marc de Perrot, MD. She listed
the three main options for treating
chronic thromboembolic pulmonary
hypertension (CTEPH) as being
pulmonary artery endarterectomy
(PEA), medical treatment with the
new drug, Riociguat, and balloon
pulmonary angioplasty.
“Of all the patients assessed in
our program, 82.7% went to surgery, with an operative mortality
rate of 2%,” said Dr. Donahoe. She
stressed that right ventricular heart
failure is an important mortality
risk and it may be necessary to use
ECMO to get RV recovery in order
to succeed.
AATS
FOCUS ON THORACIC
SURGERY: CURRENT AND
FUTURE CHALLENGES
2016
PRELIMINARY PROGRAM
NOW AVAILABLE
October 28-29, 2016
Westin Boston Waterfront Hotel
Boston, MA, USA
PROGRAM DIRECTORS
G. Alexander Patterson
David J. Sugarbaker
www.aats.org/focus
Luncheons with the Legends
AATS Daily
News
A
ttendees had the opportunity to have lunch with three luminaries: General Thoracic Surgery, Joel D. Cooper,
MD; Adult Cardiac Surgery, John L. Ochsner, MD: and Congenital Heart Disease, Leonard L Bailey, MD. Each has
made historic contributions to their profession. These luncheons were a tribute to their life’s work and provided
them an opportunity to share their expertise and wisdom.
DR. COOPER
DR. OSCHNER
DR. BAILEY
Industry Supported Symposia
Ozaki’s Aortic Valve
Neo-Cuspidization
Monday May 16 / 6:30 PM
Hilton Key Ballroom 7
Supported by JOMDD
Surgical Valve Replacement Evolving
Trends In Valve Technology
Monday May 16 / 6:45 PM
Hilton Key Ballroom 8
Supported by Edwards
The Official Newspaper of the
AATS 96th Annual Meeting
AATS STAFF
EXECUTIVE DIRECTOR
Cindy VerColen
MANAGING EDITOR
Lorraine M. O’Grady
FMC SOCIETY PARTNERS
PUBLICATION STAFF
DIRECTOR
Mark Branca
ADVERTISING SALES
Robert J. Brawn
PUBLICATION EDITORS
Therese Borden
Mark Lesney
ASSOCIATE EDITOR
Susan Hite
SENIOR DESIGNER
Michael Hyde
PHOTOGRAPHER
Martin Allred
PRODUCTION SPECIALIST
Maria Aquino
Copyright 2016, American Association for
Thoracic Surgery, 500 Cummings Center,
Suite 4550, Beverly, MA 01915. Produced
and distributed for AATS by Frontline
Medical Communications. All rights
reserved. No part of this publication may
be reproduced or transmitted in any form,
by any means, without prior permission of
the AATS. The opinions expressed in this
publication are those of the presenters and
authors, and do not necessarily reflect the
views of the Association.
Cover photo: AppalachianViews/ThinkStock
AATS
CLINICAL TRIALS
METHODS COURSE
2016
PRELIMINARY PROGRAM
NOW AVAILABLE
October 20-22, 2016
Hyatt Regency O’Hare
Chicago, IL, USA
19
PROGRAM DIRECTORS
David H. Harpole, Jr.
Marco A. Zenati
www.aats.org/clinicaltrials

Monday - American Association for Thoracic Surgery

Transcription

Similar documents

Heart Patient Panel - Mended Hearts of Central Ohio

LightMat®

MFI Employee Benefits

Awana Upcoming Events - Faith Baptist Church

Please register at helpforobesity@mcvh

Using Technology to help Train Surgeons of the Future

part 2 - EACTS

femflex

DIARYOF~A FAeELIFT HOLLYWO .....STAR S ··"(]EONS

Andy Corley Yelroc Consulting Inc.